Who
Julie Jordan
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Neurogene; Chief Medical Officer, Leverage Shares 2X Long FIX Daily ETF.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $39K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Aug 2023
- Last trade
- 26 Mar 2026
- Last filed
- 30 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Mar 2026filed 30 Mar 2026 | NGNE NeurogeneBiotechnology | SEC FORM 4 Sold | $18K828 at $21.89 | filing |
| 26 Mar 2026filed 30 Mar 2026 | NGNE NeurogeneBiotechnology | SEC FORM 4 Sold | $18K828 at $21.89 | filing |
| 20 Feb 2026filed 24 Feb 2026 | NGNE NeurogeneBiotechnology | SEC FORM 4 Code A | —4,900 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | NGNE Neurogeneoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,600 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | NGNE Neurogeneoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,600 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | NGNE NeurogeneBiotechnology | SEC FORM 4 Code A | —4,900 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | NGNE Neurogeneoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,300 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | NGNE NeurogeneBiotechnology | SEC FORM 4 Code A | —8,400 at $0.00 | filing |
| 16 Jan 2024filed 18 Jan 2024 | NGNE Neurogeneoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —1,548 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —387 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —4,644 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —1,548 at $0.00 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Sold | $606436 at $1.39 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —387 at $0.00 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Sold | $152109 at $1.39 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —4,644 at $0.00 | filing |
| 3 Aug 2023filed 7 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Sold | $1,8181,308 at $1.39 | filing |
| 2 Aug 2023filed 4 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETFoption or derivative | SEC FORM 4 Code M | —350 | filing |
| 2 Aug 2023filed 4 Aug 2023 | FIXX Leverage Shares 2X Long FIX Daily ETF | SEC FORM 4 Code M | —350 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.